Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)

NCT01510028 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Metachromatic Leukodystrophy (MLD)

Interventions

BIOLOGICAL: Recombinant human arylsulfatase A

Sponsor

Shire